Clinical Trials Sponsored by Genetic Alliance

Total 1743 results

Myriad Genetic Laboratories, Inc.
Myriad Genetics, Inc.

Completed

Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes

Hereditary Cancer

United States
Illumina, Inc.
Reprogenetics; Genesis Genetics

Completed

Single Embryo TrAnsfeR of Euploid Embryo (STAR)

Infertility | Aneuploidy

United States, Canada, Australia, United Kingdom
xCures
Cancer Commons; Genetic Alliance; LunaDNA; REDCap Cloud

Completed

Behavior, Environment And Treatments for Covid-19 (BEAT19)

Coronavirus

United States
Genesis Center for Fertility & Human Pre-Implantation...

Unknown

Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome

Cyprus
Genesis Center for Fertility & Human Pre-Implantation...

Unknown

A Novel Stimulation Protocol and the Conventional Low Dose Step-up and Step Down Regimens

PCOS

Cyprus
Genetic Immunity

Completed

Single DermaVir Immunization in HIV-1 Infected Patients on HAART (GIHU004)

HIV Infection

Hungary
Genetic Disease Investigators

Not yet recruiting

Neurological Dry Eye Study Stimulating Both Lacrimal and Vagus Nerves

Dry Eye | Dry Eye Disease
Genetic Disease Investigators

Withdrawn

Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life

Multiple Sclerosis

United States
Genetic Disease Investigators

Completed

Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life

Venous Insufficiency | Postural Orthostatic Tachycardia Syndrome | Dysautonomia | Ehlers Danlos Syndrome | External Hydrocephalus

United States
Greenwood Genetic Center

Completed

Longitudinal Studies of the Glycoproteinoses

Galactosialidosis | Sialidosis | Fucosidosis | Aspartylglucosaminuria | Alpha Mannosidosis | Beta Mannosidosis | Mucolipidosis II | Mucolipidosis III | Schindler Disease

United States
Applied Genetic Technologies Corp

Completed

Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)

X-linked Retinoschisis

United States
Myriad Genetic Laboratories, Inc.

Completed

Combined Breast Cancer Risk Study

Hereditary Cancer

United States
Myriad Genetic Laboratories, Inc.

Terminated

Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up (ONC003)

NSCLC | Lung Cancer | Lung Adenocarcinoma

United States
Iverson Genetic Diagnostics, Inc.

Suspended

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) (WARFARIN)

Atrial Fibrillation | Pulmonary Embolism | DVT | Prosthetic Replacement of Mitral Valve | Anti-coagulation Therapy | Joint Surgery Multiple

United States
Myriad Genetic Laboratories, Inc.

Completed

Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients

Prostate Cancer

United States
The Leeds Teaching Hospitals NHS Trust
Genomic Medicine Services Alliance

Completed

Modified Delphi for Genomic Bereavement Care

Genetic Disease | Bereavement | Fetal Anomaly

United Kingdom
Identifai Genetics

Recruiting

Identifai Genetics Analytic Validity Study - Compound Heterozygosity and Samples Collection

Genetics | Prenatal Diagnosis

United States
Luna Genetics

Recruiting

Cell-Based Noninvasive Prenatal Testing (NIPT)

Pregnancy Related

United States
Luna Genetics

Completed

Cell- Based Noninvasive Prenatal Testing (NIPT): Single Cell Prenatal Diagnosis (SCPD) (NIPT & SCPD)

Pregnancy Related

United States
Ambry Genetics

Completed

Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer

Breast Cancer Risk

United States
Corautus Genetics

Unknown

To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter

Angina Pectoris

United States
Myriad Genetic Laboratories, Inc.

Recruiting

Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

Prostate Cancer

United States
Myriad Genetic Laboratories, Inc.

Terminated

Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6 (PROFUSE)

Colorectal Cancer, Metastatic

United States
Applied Genetic Technologies Corp

Completed

Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)

X-Linked Retinitis Pigmentosa

United States
Myriad Genetic Laboratories, Inc.

Completed

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing (URO-009Low)

Prostate Cancer

United States
Myriad Genetic Laboratories, Inc.

Terminated

Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006) (ONC006)

NSCLC | Lung Cancer | NSCLC Adenocarcinoma

United States
Myriad Genetic Laboratories, Inc.

Withdrawn

Endometriosis Biomarker Discovery Study (EMBARK)

Endometriosis | Chronic Pelvic Pain
Myriad Genetic Laboratories, Inc.

Completed

Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients (PROCEDE-2000)

Prostate Cancer

United States
Previvo Genetics

Unknown

Controlled Ovarian Stimulation and Human Uterine Lavage

Infertility, Female

Mexico
Applied Genetic Technologies Corp

Active, not recruiting

Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)

Achromatopsia

United States, Israel
Myriad Genetic Laboratories, Inc.

Terminated

Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer

Prostate Cancer

United States
Myriad Genetic Laboratories, Inc.

Terminated

EndoPredict® Extended Endocrine Trial (EXET)

Primary Invasive Breast Cancer

United States
Esoterix Genetic Laboratories, LLC

Unknown

Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay

Fragile X Syndrome

United States
Esoterix Genetic Laboratories, LLC

Unknown

Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers

Preterm Delivery

United States
Intermountain Health Care, Inc.
Drakos Lab, University of Utah Eccles Institute for Human Genetics; Center...

Enrolling by invitation

HF Tissue Registry

Heart Failure
Sophia Genetics SAS

Recruiting

Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer (DEEP-Lung-IV)

Non-small Cell Lung Cancer Metastatic

United States, Spain, France, Israel, Germany, Canada, Italy, Brazil
Future Genetics Limited

Recruiting

EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality

Depression | Cardiovascular Diseases | Heart Failure | Epilepsy | Hypertension | Obesity | Diabetes Mellitus | Cancer | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Rheumatoid Arthritis | Peripheral Arterial Disease | Atrial Fibrillation | Asthma | Dementia | Blood Pressure | Coronary Heart Disease | Mental... and other conditions

United Kingdom
Xenetic Biosciences, Inc.

Terminated

An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer

Endometrial Cancer

United States
Future Genetics Limited

Withdrawn

EMPOWER - BAME vs COVID

Health Disparities | COVID-19, SARS-CoV 2 Infection

United Kingdom
Targeted Genetics Corporation

Completed

Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94

Rheumatoid Arthritis

Canada, United States
BeiGene
Myriad Genetic Laboratories, Inc.

Completed

The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors

Solid Tumors

United States, Spain, United Kingdom, France, Australia, New Zealand
Opus Genetics, Inc

Recruiting

Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)

LCA5

United States
Vanilloid Genetics Inc.

Unknown

Neuropeptide Therapy of Recent Onset Type 1 Diabetes

Diabetes Mellitus, Type 1

Canada
Targeted Genetics Corporation

Completed

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

Arthritis, Rheumatoid | Arthritis, Psoriatic | Ankylosing Spondylitis

United States
Interleukin Genetics, Inc.

Unknown

A to Z Study Follow-up: Collection of DNA Data From Buccal Swabs

Obesity | Weight Management | Dietary Recommendations | Diet Conditions | Overweight Management

United States
Genetic Immunity
Universitätsklinikum Hamburg-Eppendorf

Completed

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients (GIEU006)

HIV Infection

Germany
AstraZeneca
Myriad Genetic Laboratories, Inc.

Withdrawn

Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

Platinum Sensitive Relapsed Ovarian Cancer

United States, Korea, Republic of, Peru, United Kingdom, Philippines
Genetic Disease Investigators
Optos, PLC

Completed

Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI)

Multiple Sclerosis | Ehlers-Danlos Syndrome

United States
Interleukin Genetics, Inc.

Completed

Identification of Gene Biomarkers in Aging Skin

Hyperpigmentation | Skin Aging

Japan
Icon Genetics GmbH

Completed

Autologous Vaccine for Follicular Lymphoma

Lymphoma, Follicular

United States

Clinical Trials Sponsored by Genetic Alliance

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations